FIELD: pharmaceuticals.
SUBSTANCE: invention refers to compounds of general formula (IA) or their pharmaceutically acceptable stereoisomers, which have anti-inflammatory properties. In formula (IA), R1A and R2A are independently of each other H, provided that R1A and R2A both are not a hydrogen atom, a butyl group, C7-C30 alkyl group, a butyl or C7-C24 alkyl group which is covalently bonded to C6-C18 aryl group, or C6-C18 aryl group, covalently bound to butyl or C7-C24 alkyl group, or C7-C18 aryl group; Q1, Q3, Q4 and Q5 represent, independently of each other, an OH group or a caffeoyl group of formula (VI), provided that at least one of these radicals is not an OH group, and provided that compounds in which either Q3 or Q5 is a caffeoyl group, and Q1, Q4 and the other of Q3 or Q5 represent an OH group, are excluded. Invention also relates to a method for production thereof, to compounds obtained using said method, use of compounds of general formula (IA) for preventing and/or treating an inflammation or inflammatory disease, pharmaceutical composition for use in treating and/or preventing inflammation, particularly skin inflammation, or for stimulating healing, as well as to a cosmetic composition for use in treating and/or preventing skin aging, to obtain a soothing effect on skin and to stimulate regeneration of skin tissues, which contain compounds of general formula (IA).
EFFECT: disclosed are amide derivatives of polycaffeoylquinic acids, a method for production thereof and use thereof.
17 cl, 14 dwg, 7 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
CARBOCYCLIC AND HETEROCYCLIC CONDENSED COMPOUNDS OF QUINOLINE CARBOXYLIC ACID SUITED AS IMMUNODEPRESSANTS | 1994 |
|
RU2133740C1 |
HUMAN CYTOCHROME 11B2 INHIBITORS | 2021 |
|
RU2783521C1 |
HUMAN ALDOSTERONE SYNTHASE (CYP11B2) INHIBITORS | 2022 |
|
RU2811745C1 |
SELECTIVE ANDROGEN RECEPTOR DESTROYING AGENTS (SARD) AND METHODS OF USING THEREOF | 2016 |
|
RU2724103C2 |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS | 2020 |
|
RU2742879C1 |
TRIHETEROCYLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR CANCER TREATMENT | 2004 |
|
RU2360913C2 |
BORON-BASED SMALL MOLECULES AS ANTI-INFLAMMATORY DRUGS | 2007 |
|
RU2508113C2 |
HETEROCYCLIC COMPOUNDS AND USE THEREOF FOR PREVENTING OR TREATING BACTERIAL INFECTIONS | 2016 |
|
RU2714197C2 |
POLYCYCLIC MACROLACTAMS AND PHARMACEUTICAL COMPOSITION BASED ON THEM | 1993 |
|
RU2126009C1 |
2-THIADIBENZOAZULENES AS INHIBITORS OF TUMOUR NECROSIS FACTOR PRODUCING AND INTERMEDIATE PRODUCTS FOR PRODUCTION THEREOF | 2003 |
|
RU2334749C2 |
Authors
Dates
2021-02-10—Published
2017-04-26—Filed